Drug Shortage Report for JAMP-SOTALOL
| Report ID | 137090 |
| Drug Identification Number | 02368617 |
| Brand name | JAMP-SOTALOL |
| Common or Proper name | Sotalol |
| Company Name | JAMP PHARMA CORPORATION |
| Market Status | DORMANT |
| Active Ingredient(s) | SOTALOL HYDROCHLORIDE |
| Strength(s) | 80MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL ORAL |
| Packaging size | 100 |
| ATC code | C07AA |
| ATC description | BETA BLOCKING AGENTS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2019-12-01 |
| Estimated end date | 2022-12-30 |
| Actual end date | |
| Shortage status | Actual shortage |
| Updated date | 2021-04-07 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 1310 RUE NOBEL BOUCHERVILLE, QUEBEC CANADA J4B 5H3 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v1 | 2021-04-07 | English | Compare |
| v2 | 2021-04-07 | French | Compare |
Showing 1 to 2 of 2